z-logo
open-access-imgOpen Access
Stages of Adoption of “Treatment as Prevention” Among HIV-Negative Men Who Have Sex with Men Who Engage in Exchange Sex
Author(s) -
Étienne Meunier,
Karolynn Siegel,
Anne E. Sundelson,
Eric W. Schrimshaw
Publication year - 2020
Publication title -
aids patient care and stds
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.504
H-Index - 85
eISSN - 1557-7449
pISSN - 1087-2914
DOI - 10.1089/apc.2020.0062
Subject(s) - treatment as prevention , men who have sex with men , medicine , human immunodeficiency virus (hiv) , stigma (botany) , qualitative research , promotion (chess) , transmission (telecommunications) , viral load , clinical psychology , family medicine , psychiatry , antiretroviral therapy , syphilis , sociology , politics , political science , law , engineering , social science , electrical engineering
Prior research found low acceptability of HIV treatment as prevention (TasP; or Undetectable = Untransmittable ) among HIV-negative men who have sex with men (MSM). This study reports on qualitative data regarding TasP adoption in a sample of 170 self-reported HIV-negative MSM who had engaged in exchange sex (received money, drugs, or other things in exchange for sex). We classified participants along five stages of TasP adoption: 1-unaware of TasP (11.2%); 2-aware, but perceived ineffective (17.1%); 3-perceived effective, but unwilling to use (35.3%); 4-willing to rely on TasP, but had never done so (24.1%); and 5-had relied on TasP (12.4%). Obstacles to TasP adoption included the following: not believing that it could completely prevent HIV transmission; deeply ingrained fears of HIV/AIDS; concerns about viral load fluctuation; and reluctance to trust a partner's claimed undetectable status. TasP promotion efforts, which can decrease barriers to HIV testing and HIV stigma, will be more effective if tailored to the obstacles specific to each stage of TasP adoption.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here